Table 1 Patient baseline information and characteristics
Total patients | 13 | |
|---|---|---|
Sex | Male | 7 (53.8%) |
Female | 6 (46.2%) | |
Age (years) | Median [25, 75%] | 28 [23–30] |
Body weight (kg) | Median [25, 75%] | 53.0 [47.4–70.2] |
Mean ± SD | 59.1 ± 16.9 | |
BSA (m2) | Median [25, 75%] | 1.52 [1.47–1.74] |
Mean ± SD | 1.62 ± 0.23 | |
BMI (kg/m2) | Median [25, 75%] | 19.0 [18.3–27.3] |
Mean ± SD | 22.2 ± 5.1 | |
Regular use of drugs | Histamine H1 blocker | 0 (0.0%) |
Histamine H2 blocker | 4 (30.8%) | |
Analgesic drug | 0 (0.0%) | |
Prednisolone | 13 (100%) | |
Cyclosporine | 10 (76.9%) | |
Mizoribine | 1 (7.7%) | |
Mycophenolate mofetil | 0 (0.0%) | |
Prednisolone dosage (mg/day) | Median [25, 75%] | 17.5 [10.0–25.0] |
Details of premedication (presence/absence of 4 mg of intravenous betamethasone) | Presence | 11 (84.6%) |
Absence | 2 (15.4%) |